X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (57) 57
female (50) 50
index medicus (43) 43
middle aged (43) 43
male (37) 37
adult (35) 35
rheumatology (31) 31
rheumatoid arthritis (30) 30
aged (23) 23
arthritis, rheumatoid - drug therapy (14) 14
treatment outcome (14) 14
medicine, general & internal (12) 12
cancer (10) 10
immunology (10) 10
oncology (10) 10
taiwan (10) 10
antirheumatic agents - therapeutic use (9) 9
care and treatment (9) 9
medicine (9) 9
patients (9) 9
risk factors (9) 9
systemic lupus erythematosus (9) 9
arthritis (8) 8
chemotherapy (8) 8
disease (8) 8
internal medicine (8) 8
methotrexate (8) 8
retrospective studies (8) 8
aged, 80 and over (7) 7
autoimmune diseases (7) 7
classification (7) 7
drug therapy (7) 7
image segmentation (7) 7
medicine & public health (7) 7
research (7) 7
adalimumab (6) 6
analysis (6) 6
criteria (6) 6
diagnosis (6) 6
enzyme-linked immunosorbent assay (6) 6
hospitals (6) 6
infection (6) 6
rheumatoid factor (6) 6
tumor necrosis factor-tnf (6) 6
adolescent (5) 5
association (5) 5
case-control studies (5) 5
etanercept (5) 5
expression (5) 5
hepatitis (5) 5
hepatitis b (5) 5
infections (5) 5
lupus (5) 5
medical research (5) 5
research article (5) 5
studies (5) 5
surgery (5) 5
systemic-lupus-erythematosus (5) 5
tumor necrosis factor (5) 5
abridged index medicus (4) 4
animals (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
arthritis, rheumatoid - blood (4) 4
arthritis, rheumatoid - complications (4) 4
arthritis, rheumatoid - immunology (4) 4
carcinoma (4) 4
clinical trials (4) 4
cytokines (4) 4
deoxyribonucleic acid--dna (4) 4
disease-activity (4) 4
diseases (4) 4
dose-response relationship, drug (4) 4
double-blind (4) 4
drug combinations (4) 4
fluorescence (4) 4
follow-up studies (4) 4
health aspects (4) 4
incidence (4) 4
infectious diseases (4) 4
inflammation (4) 4
management (4) 4
mice (4) 4
microscopy (4) 4
monoclonal-antibody (4) 4
musculoskeletal diseases (4) 4
pattern classification (4) 4
pharmacology & pharmacy (4) 4
physiological aspects (4) 4
rheumatism (4) 4
rheumatoid-arthritis (4) 4
scintigraphy (4) 4
skin and connective tissue diseases (4) 4
time factors (4) 4
treatment (4) 4
trial (4) 4
tumor-necrosis-factor (4) 4
adult-onset still's disease (3) 3
adult‐onset still's disease (3) 3
american-college (3) 3
antibodies, monoclonal - therapeutic use (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2011, Volume 70, Issue 10, pp. 1719 - 1725
Objective To investigate the kinetics of hepatitis B virus (HBV) viral loads and HBV reactivation in rheumatoid arthritis (RA) patients undergoing therapy with... 
FULMINANT-HEPATITIS | LAMIVUDINE | IMMUNOSUPPRESSIVE THERAPY | SAFETY | DISEASE | BLOCKING AGENTS | INFECTION | RHEUMATOLOGY | TNF | HBV | METHOTREXATE THERAPY | Hepatitis B, Chronic - immunology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Arthritis, Rheumatoid - complications | Viral Load | Hepatitis B Surface Antigens - blood | Hepatitis B, Chronic - prevention & control | Receptors, Tumor Necrosis Factor - therapeutic use | Antibodies, Monoclonal, Humanized | Hepatitis B Antibodies - blood | Etanercept | Arthritis, Rheumatoid - drug therapy | Lamivudine - therapeutic use | Antirheumatic Agents - adverse effects | Immunoglobulin G - pharmacology | Adult | Female | Retrospective Studies | Antirheumatic Agents - pharmacology | Immunosuppressive Agents - pharmacology | Antirheumatic Agents - therapeutic use | Antiviral Agents - therapeutic use | Antibodies, Monoclonal - pharmacology | Immunoglobulin G - therapeutic use | Hepatitis B virus - physiology | Immunoglobulin G - adverse effects | Hepatitis B, Chronic - virology | Hepatitis B, Chronic - complications | Virus Activation - drug effects | Immunosuppressive Agents - adverse effects | Hepatitis B virus - isolation & purification | Adalimumab | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antigens | Occult sciences | Rheumatology | Cytotoxicity | Infections | Risk factors | Studies | Hepatitis | Rheumatoid arthritis | Gangrene | Tumor necrosis factor-TNF | Mutation | Deoxyribonucleic acid--DNA
Journal Article
Journal Article
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 08/2019, Volume 21, Issue 1, pp. 196 - 9
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 02/2019, Volume 52, Issue 1, pp. 141 - 150
To evaluate the long-term safety and effectiveness of tocilizumab (TCZ) for the treatment of rheumatoid arthritis (RA) in a real-world clinical setting in... 
Safety and effectiveness | Tuberculosis | Tocilizumab | Rheumatoid arthritis | Hepatitis B | CRITERIA | INFECTIOUS DISEASES | POSTMARKETING SURVEILLANCE | RECEPTOR INHIBITION | RISK | CLASSIFICATION | MICROBIOLOGY | IMMUNOLOGY | INTERLEUKIN-6 | LIPID PROFILE | INFECTION | HEPATITIS-B
Journal Article
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 06/2018, Volume 21, Issue 6, pp. 1163 - 1172
Aim Membranous lupus glomerulonephritis (MLN) is associated with morbidities such as thromboembolism, peripheral edema and/or hyperlipidemia. However,... 
lupus nephritis | systemic lupus erythematosus | tacrolimus | mycophenolic acid | MANAGEMENT | CYCLOPHOSPHAMIDE | RHEUMATOLOGY | NEPHROPATHY | ERYTHEMATOSUS | CYCLOSPORINE-A | COHORT | NEPHROTIC SYNDROME | CHINESE PATIENTS | MYCOPHENOLATE-MOFETIL | Proteinuria - immunology | Humans | Immunosuppressive Agents - therapeutic use | Risk Factors | Induction Chemotherapy | Lupus Nephritis - drug therapy | Male | Treatment Outcome | Lupus Nephritis - immunology | Remission Induction | Opportunistic Infections - chemically induced | Opportunistic Infections - microbiology | Proteinuria - drug therapy | Glomerulonephritis, Membranous - drug therapy | Glomerulonephritis, Membranous - immunology | Glomerulonephritis, Membranous - diagnosis | Adult | Female | Immunosuppressive Agents - adverse effects | Opportunistic Infections - immunology | Immunocompromised Host | Odds Ratio | Lupus Nephritis - diagnosis | Lupus | Yuan (China) | Medical research | Care and treatment | Nephritis | Corticosteroids | Systemic lupus erythematosus | Analysis | Medicine, Experimental | Mycophenolate mofetil | Thromboembolism | Glomerulonephritis | Corticoids | Edema | Mycophenolic acid | Hyperlipidemia | Calcineurin | Calcineurin inhibitors | Clinical trials | Lupus nephritis | Patients | Immunosuppressive agents | Conditioned stimulus | Remission | Proteinuria
Journal Article